Literature DB >> 4666121

Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.

T A Miettinen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4666121     DOI: 10.1016/0021-9150(72)90066-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  6 in total

Review 1.  Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  The effect of probucol on the proliferation of cultured human umbilical vascular endothelial cells.

Authors:  T Tajika; Y Ono; K Ono; M Miura; Y Kyo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

Review 3.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

4.  Usefulness of probucol in treating primary hypercholesterolemia.

Authors:  M Enjalbert; S Lussier-Cacan; S DuBreuil-Quidoz; J LeLorier; J Davignon
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

5.  Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.

Authors:  N Tanno; S Oikawa; M Koizumi; H Kotake; H Hirakawa; Y Kanazawa; T Toyota
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

6.  An overview of the biochemical pharmacology of probucol.

Authors:  J W Barnhart; D J Rytter; J A Molello
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.